OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Carmela Abraham

6 Projects | 1 Researchers | $1,434,044 Invested

2016

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD (Bridge Funding)

  • Funding Amount: $215,293
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2015

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD (Follow-On Funding)

  • Funding Amount: $236,516
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2014

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD

  • Funding Amount: $344,305
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2013

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD

  • Funding Amount: $266,509
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2012

Boston University

Carmela Abraham, PhD

Development of Klotho Enhancers as Novel Therapeutics for AD This is a request for Renewal/Follow-on funding.

  • Funding Amount: $196,421
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2009

Boston University

Carmela Abraham, PhD

Development of Klotho enhancers as novel therapeutics for AD

  • Funding Amount: $175,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed